STM2120 is a METTL3-METTL14 inhibitor with an IC50 of 64.5 μM.
STM2120 (0.04-50 μM; 72 h) shows no effect on the proliferation of MOLM-13 cells[1].
References:
[1]. Yankova E, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021 May;593(7860):597-601.
















